Novartis Investigative Site
Asheville, North Carolina 28803
We've found
8 trials
at this facility
Non-Alcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
Updated: 4/4/2016
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling,
Phase
IV
Updated: 4/4/2016
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
Updated: 12/31/1969
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials